Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 44
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Phys Rev Lett ; 94(1): 012003, 2005 Jan 14.
Artigo em Inglês | MEDLINE | ID: mdl-15698070

RESUMO

Single pi(0) photoproduction has been studied with the CB-ELSA experiment at Bonn using tagged photon energies between 0.3 and 3.0 GeV. The experimental setup covers a very large solid angle of approximately 98% of 4pi. Differential cross sections dsigma/dOmega have been measured. Complicated structures in the angular distributions indicate a variety of different resonances being produced in the s channel intermediate state gammap-->N(*)(Delta(*))-->ppi(0). A combined analysis including the data presented in this letter along with other data sets reveals contributions from known resonances and evidence for a new resonance N(2070)D15.

2.
Phys Rev Lett ; 94(1): 012004, 2005 Jan 14.
Artigo em Inglês | MEDLINE | ID: mdl-15698071

RESUMO

Total and differential cross sections for the reaction p(gamma,eta)p have been measured for photon energies in the range from 750 MeV to 3 GeV. The low-energy data are dominated by the S11 wave which has two poles in the energy region below 2 GeV. Eleven nucleon resonances are observed in their decay into peta. At medium energies we find evidence for a new resonance N(2070)D15 with (M,Gamma)=(2068+/-22, 295+/-40) MeV. At gamma energies above 1.5 GeV, a strong peak in the forward direction develops, signaling the exchange of vector mesons in the t channel.

3.
Mycoses ; 39(1-2): 1-3, 1996.
Artigo em Inglês | MEDLINE | ID: mdl-8786751

RESUMO

In this paper a new fungus species, Exophiala mesophila Listemann et Freiesleben, is described. The species was isolated from silicone seals in the shower room of a hospital ward.


Assuntos
Exophiala/classificação , Animais , Exophiala/citologia , Exophiala/isolamento & purificação , Alemanha , Humanos , Quartos de Pacientes
11.
Infection ; 11 Suppl 1: S54-6, 1983.
Artigo em Inglês | MEDLINE | ID: mdl-6299968

RESUMO

The therapeutic efficacy and pharmacokinetics of the cephalosporins ceftazidime, ceftizoxime, cefotaxime and HR 221 were studied in animal experiments. The animal model used was experimental estrogen-induced or non-induced chronic Escherichia coli pyelonephritis in rats. The animals were treated with 5 mg cephalosporin/kg twice daily for one week. Each of the cephalosporins tested led to a significant decrease in renal bacterial counts, in spite of the low doses given. Ceftazidime was significantly more active than HR 221 in both experimental models, although the serum levels of HR 221 were higher and were maintained for a longer period of time than those of ceftazidime. Differences in pharmacokinetic properties (influenced by metabolic stability and protein binding) could be the reason for the differences in therapeutic activity, since the in vitro antimicrobial activity of each of the cephalosporins tested was very similar against the test strain.


Assuntos
Cefalosporinas/uso terapêutico , Infecções por Escherichia coli/tratamento farmacológico , Animais , Cefotaxima/análogos & derivados , Cefotaxima/uso terapêutico , Ceftazidima , Ceftizoxima , Cefalosporinas/metabolismo , Doença Crônica , Avaliação Pré-Clínica de Medicamentos , Pielonefrite/tratamento farmacológico , Ratos
13.
Dtsch Med Wochenschr ; 105(39): 1341-4, 1980 Sep 26.
Artigo em Alemão | MEDLINE | ID: mdl-6970118

RESUMO

In a multi-center study 523 strains of H. influenzae and H. parainfluenzae isolated from patients in eight towns of the Federal Republic of Germany were tested for their sensitivity to 15 different chemotherapeutic agents. 1.7% of the strains were resistant to ampicillin, 1,5% to chloramphenicol and 2.5% to tetracycline. All ampicillin-resistant strains produced beta-lactamase. For the first time, multiple resistant strains were isolated: two against ampicillin, chloramphenicol and tetracycline; one in addition also against co-trimoxazole. It is likely that there will be a spread of such resistant strains.


Assuntos
Haemophilus influenzae/efeitos dos fármacos , Ampicilina/farmacologia , Cloranfenicol/farmacologia , Alemanha Ocidental , Resistência às Penicilinas , Sulfametoxazol/farmacologia , Tetraciclina/farmacologia , Trimetoprima/farmacologia
14.
Hautarzt ; 31(8): 444-6, 1980 Aug.
Artigo em Alemão | MEDLINE | ID: mdl-7451151

RESUMO

19 patient received penicillin and probenecid. The resulting serum concentrations of penicillin was determined. In regimen I 4 mill. IU depot penicillin was given i.m. simultaneously with 1 g probenecid orally. In regimen II probenecid was given 30 min prior to the administration of penicillin. In both series the average serum concentrations of penicillin were not significantly different (p = 0.01).


Assuntos
Gonorreia/tratamento farmacológico , Penicilina G/uso terapêutico , Probenecid/uso terapêutico , Adolescente , Adulto , Quimioterapia Combinada , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Penicilina G/sangue
15.
Dtsch Med Wochenschr ; 104(26): 946-8, 1979 Jun 29.
Artigo em Alemão | MEDLINE | ID: mdl-110574

RESUMO

The in-vitro activity of nalidixic acid and pipemidic acid was investigated in a combined study in 450 freshly isolated bacterial strains using the agar dilution test. Gram-positive cocci were resistant to both substances except for a few pipemidic acid sensitive staphylococci. Both substances had good antibacterial activity in the gram-negative spectrum. However, the MIC values of pipemidic acid were generally clearly lower than those of nalidixic acid. Only pipemidic acid showed activity against Pseudomonas aeruginosa. Thus the in-vitro results showed that pipemidic acid has clear-cut and valuable advantages for the treatment of urinary tract infections when compared with nalidixic acid.


Assuntos
Antibacterianos , Bactérias/efeitos dos fármacos , Ácido Nalidíxico/farmacologia , Ácidos Nicotínicos/farmacologia , Ácido Pipemídico/farmacologia , Fenômenos Químicos , Química , Enterobacter/efeitos dos fármacos , Escherichia coli/efeitos dos fármacos , Klebsiella/efeitos dos fármacos , Proteus mirabilis/efeitos dos fármacos , Pseudomonas aeruginosa/efeitos dos fármacos , Especificidade da Espécie
17.
Arzneimittelforschung ; 29(2a): 414-6, 1979.
Artigo em Inglês | MEDLINE | ID: mdl-385009

RESUMO

The therapeutic effectiveness of (6R,7R)-7-(2-[3,5-dichloro-4-oxo-1(4H)-pyridyl]-acetamido)-3-([(5-methyl-1,3,4-thiadiazol-2-yl)-thio]methyl)-8-oxo-5-thia-1-azabicyclo[4,2,0]oct-2-ene-2-carboxylic acid (cefazedone, Refosporen), cephazolin, cephacetrile and cephalothin was compared in the test model of estradiol-induced E. coli pyelonephritis in the rat. Cefazedone and cephazolin were similar in effect. The relations between results of treatment and microbiological and pharmacokinetic characteristics of the cephalosporins tested are discussed.


Assuntos
Cefalosporinas/uso terapêutico , Infecções por Escherichia coli/tratamento farmacológico , Pielonefrite/tratamento farmacológico , Animais , Cefalosporinas/metabolismo , Feminino , Cinética , Pielonefrite/etiologia , Ratos
18.
Arzneimittelforschung ; 29(6): 932-4, 1979.
Artigo em Inglês | MEDLINE | ID: mdl-582786

RESUMO

Eleven cephalosporins were tested for their pharmacokinetic properties in rats in order to obtain a basis for experimental evaluation of their in vivo activity. The compounds were administered to female Wistar rats in i.m. doses of 150 or 50 mg/kg. The cephalosporin concentrations in rat serum were determined by the agar-well-diffusion method. Essential differences concerning the serum levels, half-life and the area under the curve could be ascertained. Low serum levels and short half-life could be reported for cephapirin, cephalotin, and cephradin, whereas cefazolin, cefazedone, and cefuroxime produced high and longer lasting serum levels. All cephalosporins were quickly absorbed, most of them were beneath the minimum detectable concentration after 6 h. It is concluded that pharmacokinetic data should be taken into consideration in conjunction with experimental chemotherapy.


Assuntos
Cefalosporinas/sangue , Animais , Cefalosporinas/administração & dosagem , Feminino , Meia-Vida , Injeções Intramusculares , Ratos , Fatores de Tempo
19.
Arzneimittelforschung ; 29(6): 940-5, 1979.
Artigo em Alemão | MEDLINE | ID: mdl-582788

RESUMO

Pharmacokinetics, nephrotoxicity, and therapeutic efficacy of (2S-cis)-4-O-[3-amino-6-(aminomethyl)-3,4-dihydro-2H-pyran-2-yl]-2-deoxy-6-O-[3-deoxy-4-C-methyl-3-(methyl-amino)-beta-L-arabinopyranosyl]-N1-ethyl-D-streptamine sulfate (netilmicin) and tobramycin were investigated in rats. The excretion rates of tubular cells and of the urinary enzyme malic dehydrogenase served as parameter of nephrotoxicity. Both compounds were, similar to other aminoglycosides, tubulotoxic within the range of dosages used for human therapy. Netilmicin, however, produced less renal damage than did tobramycin in all dosages applied. Pharmacokinetic studies revealed lower renal concentrations of netilmicin after repetitive administration. Experimental chemotherapy of the chronic E. coli pyelonephritis in rats with both aminoglycosides resulted in a significant reduction of the renal bacterial counts. In spite of approximately identical serum concentration curves and in vitro activity, especially the low dosage of netilmicin led to more favourable therapeutic results than equal doses of tobramycin. These animal experiments suggest higher renal tolerance and efficacy of netilmicin.


Assuntos
Antibacterianos/farmacologia , Infecções Bacterianas/tratamento farmacológico , Gentamicinas/farmacologia , Nefropatias/induzido quimicamente , Netilmicina/farmacologia , Tobramicina/farmacologia , Animais , Feminino , Cinética , Netilmicina/metabolismo , Netilmicina/uso terapêutico , Ratos , Fatores de Tempo , Tobramicina/metabolismo , Tobramicina/uso terapêutico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...